Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review article: managing the adverse events caused by anti‐TNF therapy in inflammatory bowel disease
Uday N. Shivaji, C Sharratt, Tom Thomas, et al.
Alimentary Pharmacology & Therapeutics (2019) Vol. 49, Iss. 6, pp. 664-680
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
Torsten Kucharzik, Pierre Ellul, Thomas Greuter, et al.
Journal of Crohn s and Colitis (2021) Vol. 15, Iss. 6, pp. 879-913
Open Access | Times Cited: 313
Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases
Laurent Beaugerie, Jean‐François Rahier, Julien Kirchgesner
Clinical Gastroenterology and Hepatology (2020) Vol. 18, Iss. 6, pp. 1324-1335.e2
Open Access | Times Cited: 106
The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease
Shengjie Ma, Jiaxin Zhang, Heshi Liu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 53
Bovine colostrum derived-exosomes prevent dextran sulfate sodium-induced intestinal colitis via suppression of inflammation and oxidative stress
Geonhee Han, Haeun Cho, Hyo‐Suk Kim, et al.
Biomaterials Science (2022) Vol. 10, Iss. 8, pp. 2076-2087
Closed Access | Times Cited: 40
Targeting cytokines in inflammatory bowel disease
Markus F. Neurath
Science Translational Medicine (2022) Vol. 14, Iss. 675
Closed Access | Times Cited: 40
Wielding the double-edged sword: Redox drug delivery systems for inflammatory bowel disease
Yi Chen, Mingju Shui, Qin Yuan, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 510-540
Closed Access | Times Cited: 36
Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis
Airu Liu, Xiaonan Liang, Wenxin Wang, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center
Roxana Elena Matran, Andra-Mihaela Diaconu, Andreea Maria Iordache, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 84-84
Open Access | Times Cited: 1
IgA vasculitis induced by tumor necrosis factor-α antagonists: clinical features, diagnosis and management
Yan Lu, Jie Shen, Lin Liu, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access | Times Cited: 1
Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease
Charles Caër, Mary Jo Wick
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 67
TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User’s Guide: An Update
Marianne Vullièmoz, Stephan Brand, Pascal Juillerat, et al.
Digestion (2020) Vol. 101, Iss. Suppl. 1, pp. 16-26
Open Access | Times Cited: 63
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease
Matthew Bohm, Ronghui Xu, Yiran Zhang, et al.
Alimentary Pharmacology & Therapeutics (2020) Vol. 52, Iss. 4, pp. 669-681
Open Access | Times Cited: 61
Ferrostatin-1 alleviated TNBS induced colitis via the inhibition of ferroptosis
Junxuan Xu, Si Liu, Zilu Cui, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 573, pp. 48-54
Closed Access | Times Cited: 56
Berberine-Loaded Carboxylmethyl Chitosan Nanoparticles Ameliorate DSS-Induced Colitis and Remodel Gut Microbiota in Mice
Luqing Zhao, Xueying Du, Jiaxin Tian, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 45
Selective JAK1 inhibitors for the treatment of inflammatory bowel disease
Ole Haagen Nielsen, Theresa Louise Boye, John Gubatan, et al.
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108402-108402
Open Access | Times Cited: 22
Autophagy: A potential target for natural products in the treatment of ulcerative colitis
Wei Zhang, Menglong Zou, Jia Fu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116891-116891
Open Access | Times Cited: 8
Oral chondroitin sulfate functionalized natural polyphenol for targeted therapy of ulcerative colitis
Yi Chen, Mingju Shui, Qin Yuan, et al.
Materials & Design (2024) Vol. 238, pp. 112645-112645
Open Access | Times Cited: 7
Carcinoembryonic antigen (CEACAM) family members and Inflammatory Bowel Disease
Maebh Kelleher, Raminder Singh, Caitríona M. O’Driscoll, et al.
Cytokine & Growth Factor Reviews (2019) Vol. 47, pp. 21-31
Closed Access | Times Cited: 49
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy
Roberta Roberti, Luigi Francesco Iannone, Caterina Palleria, et al.
Current Medical Research and Opinion (2020) Vol. 36, Iss. 9, pp. 1457-1463
Closed Access | Times Cited: 49
Mesopore to Macropore Transformation of Metal–Organic Framework for Drug Delivery in Inflammatory Bowel Disease
Yi Yin, Jingjing Yang, Yongchun Pan, et al.
Advanced Healthcare Materials (2020) Vol. 10, Iss. 3
Closed Access | Times Cited: 42
<p>Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy</p>
Jessica Dahmus, Michelle Rosario, Kofi Clarke
Clinical and Experimental Gastroenterology (2020) Vol. Volume 13, pp. 339-350
Open Access | Times Cited: 41
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
Laurent Peyrin‐Biroulet, William J. Sandborn, Remo Panaccione, et al.
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 41
Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities
Amit Srivastava, Tara Chand Yadav, Harvinder Kour Khera, et al.
Journal of Autoimmunity (2021) Vol. 118, pp. 102614-102614
Closed Access | Times Cited: 39
Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases
Vesna Risso, Élodie Lafont, Matthieu Le Gallo
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 24
Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases
Sruthi Vijaya Retnakumar, Sylviane Muller
Trends in Molecular Medicine (2019) Vol. 25, Iss. 6, pp. 516-537
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top